期刊文献+

酰肼交联透明质酸衍生物的生物相容性研究 被引量:5

The biocompatibility of the hyaluronan derivatives cross-linked by adipic dihydrazide
下载PDF
导出
摘要 目的评价酰肼交联透明质酸衍生物(HA-ADH)的生物相容性。方法采用咔唑法测定HA-ADH在体外对透明质酸酶(HAse)的抗酶解性;HA-ADH植入大鼠皮下,间隔5d或10d处死,测定植入物重量,观察HA-ADH在体内的存留时间和局部刺激。结果体外酶降解实验结果表明,HAse的浓度与降解产物之间呈线性关系;HA-ADH在体外的抗酶解性与其交联度密切相关,交联度大的样品抗酶性强;HA-ADH在体内的降解曲线显示植入物降解速度先快后慢,植入样品在大鼠体内存留15d以上,交联度大的样品存留时间长;试验期间未发现局部刺激反应。结论HA-ADH具有抗酶解性和较好的生物相容性,是一种具有开发潜力的可降解性植入材料。 Objective To evaluate the biocompatibility of the hyaluronan derivatives cross-linked by adipic dihydrazide (HADH). Methods The resistance to hyaluronidase (HAase) degradation of the derivatives of HA-ADH in vitro was measured by carbazole method. The derivatives of HA-ADH were implanted subcutaneously in rats and Weighed aider the rats were executed in batches aider or at an interval of 5 or 10 days. The turnover and its localirritation of the derivatives were examined, Results The result of in vitro degradation demonstrated a linear relationship between the concentration of HAase and the products of degradation. The resistance to HAase of the derivatives was correlated with its cross-linking degree intimately. The derivatives with high cross-linking degree was more resistant to enzymatic degradation than those with low cross-linking degree. The plot of in vivo degradation of the derivatives indicated the turnover rate of the implant was quick in the earlier period, then stepped down in the later period. The turnovers of all derivatives was over 15 days. The derivatives with high cross-linking degree were more persistent. No local stimulation on rats was observed during the experiment. Conclusion The derivatives of HA-ADH are resistant to enzymatic degradation and biocompatible. They have excellent potentials as degradable and implantable materials.
出处 《食品与药品》 CAS 2005年第08A期37-40,共4页 Food and Drug
关键词 交联透明质酸 体内植入 生物相容性 抗酶解性 cross-linked hyaluronan implant in vivo biocompatibility
  • 相关文献

参考文献17

  • 1凌沛学,贺艳丽.玻璃酸钠的临床研究应用进展[J].中国生化药物杂志,1998,19(4):200-205. 被引量:60
  • 2张丽荣,冷玉敏,贺艳丽,凌沛学.眼用溶液的载体──玻璃酸钠的作用机理和应用[J].中国生化药物杂志,1999,20(5):251-253. 被引量:13
  • 3Laurent TC, Laurent UBG, Fraser JRE. Functions of hyaluronan [J].Ann Rheum Dis, 1995,54(5):429-432.
  • 4Gao KL, Benlield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing[J]. Drugs ,1994, 47(3): 536-566.
  • 5Adam ME. Viscosupplementation as articular therapy[A].In: Laurent TC. The chemistry, biology and medical application ofhyaluronan and its derivatives [M]. London: Portland Press, 1998:243-254.
  • 6Moore AR,Willoughby DA. Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action [J].Int J Tissue React, 1995, 17(4):153-156.
  • 7Miller JA, Ferguson RL, Powers DL, et al. Efficacy of hyaluronic acid/nonsteroidal anti-inflammatory drug systems in preventing postsurgical tendon adhesions [J]. J Biomed Mater Res (Appl Biomater), 1997, 38(1):25-33.
  • 8Fessler JH,Fessler LI. Electron microscope visualization of the polysaccharide hyaluronic acid[J].Proc Natl Acad sci USA,1966,56(1):141-147.
  • 9Cleland RL,Wang JL.Ionic polysaccharides. Ⅲ.Dilute solution properties of hyaluronic acid fractions[J]. Biochem J,1972,128(5): 1255-1263.
  • 10Scott JE,Cummings C,Brass A,et al. Secondary and tertiary structrures ofhyaluronan in aqueous soliution,investigated by rotary shadowing-electron microscopy and computer simulation[J].Biochem J, 1991,274(Pt 3):699-705.

二级参考文献4

共引文献67

同被引文献69

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部